Control of multidrug-resistant Gram-negative bacteria in low- and middle-income countries—high impact interventions without much resources N. Singh,

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

Twelve years of dengue surveillance in Belgian travellers and significant increases in the number of cases in 2010 and 2013 J. Verschueren, L. Cnops,

Gut bacterial microbiota and obesity

I.J. Schalk Clinical Microbiology and Infection

Salvage therapy for multidrug-resistant tuberculosis

O.J. Dyar, G. Tebano, C. Pulcini Clinical Microbiology and Infection

D. Khalil, M. Hultin, M.U. Rashid, B. Lund

Time-trends for Gram-negative and multidrug-resistant Gram-positive bacteria associated with nosocomial infections in German intensive care units between.

The efficacy and safety of daptomycin: first in a new class of antibiotics for Gram- positive bacteria M.J. Rybak Clinical Microbiology and Infection

Migrant health—a cause for concern?

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

J.-P. Van geertruyden Clinical Microbiology and Infection

O. Clerc, G. Greub Clinical Microbiology and Infection

Refugee crisis and re-emergence of forgotten infections in Europe

Impact of inadequate initial antimicrobial therapy on mortality in patients with bacteraemic cholangitis: a retrospective cohort study Y. Tagashira,

Controversies in guidelines for the control of multidrug-resistant Gram-negative bacteria in EU countries J.A. Otter, N.T. Mutters, E. Tacconelli, A.

R. Cantón Clinical Microbiology and Infection

A.E. Muller, U. Theuretzbacher, J.W. Mouton

Louis Pasteur, from crystals of life to vaccination

How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development R. Bax Clinical Microbiology.

Should standardized susceptibility testing for microbial biofilms be introduced in clinical practice? T. Coenye, D. Goeres, F. Van Bambeke, T. Bjarnsholt

Surveillance of Legionnaires’ disease in Austria

How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach D. Guillemot Clinical Microbiology.

H. Adibhesami, M. Douraghi, M. Rahbar, A. Abdollahi

Vector control: a cornerstone in the malaria elimination campaign

Enhanced surveillance of carbapenemase-producing Gram-negative bacteria to support national and international prevention and control efforts R. Freeman

Training for the infectious diseases speciality in Norway

Good epidemiological practice: a narrative review of appropriate scientific methods to evaluate the impact of antimicrobial stewardship interventions

Isospora belli Clinical Microbiology and Infection

B. Gordts Clinical Microbiology and Infection

CMI editorial report 2011 Clinical Microbiology and Infection

Performance of hepatitis C virus (HCV) direct-acting antivirals in clinical trials and daily practice J.E. Arends, P.A.M. Kracht, A.I.M. Hoepelman Clinical.

Salvage therapy for multidrug-resistant tuberculosis

In vitro selection of antibiotic resistance in Pseudomonas aeruginosa

R. Bitterman, M. Paul, D. Polak, Y. Geffen

Acute schistosomiasis, a diagnostic and therapeutic challenge

Metagenomics and probiotics

M. Aires-de-Sousa Clinical Microbiology and Infection

Previously unknown species of Aspergillus

Sexually acquired Zika virus: a systematic review

Systematic review of antibiotic consumption in acute care hospitals

Update on antifungal resistance in Aspergillus and Candida

Harmonised monitoring of antimicrobial resistance in Salmonella and Campylobacter isolates from food animals in the European Union S. Bronzwaer Clinical.

Abstracts cont. Clinical Microbiology and Infection

A novel fluorescence in situ hybridization test for rapid pathogen identification in positive blood cultures A. Makristathis, S. Riss, A.M. Hirschl

Accurate hepatitis C virus genotyping and selection of optimal therapy: lessons from a St Petersburg strain infection E. Knops, E. Heger Clinical Microbiology.

C. Tamalet, P. Colson, E. Decroly, C. Dhiver, I. Ravaux, A. Stein, D

Antimicrobial drug development – the past, the present, and the future

An after-hours clinical liaison blood culture service—is it worth it?

G.M. Rossolini, E. Mantengoli Clinical Microbiology and Infection

Clinical Microbiology and Infection

Clinical Microbiology and Infection

J.-M. Rolain, C. Abat, P. Brouqui, D. Raoult

K. Kaier, N.T. Mutters, U. Frank Clinical Microbiology and Infection

Survival of rhinoviruses on human fingers

The atypical pneumonias: clinical diagnosis and importance

Abstracts Clinical Microbiology and Infection

Virology: a scientific discipline facing new challenges

Modelling during an emergency: the 2009 H1N1 influenza pandemic

New oral cephalosporins in pediatric community-acquired infections

R. Khatib, G. Simeunovic, M. Sharma, M. G. Fakih, L. B. Johnson, L

B.A. Cunha Clinical Microbiology and Infection

Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group† H. Goossens Clinical.

J.L. Balcázar Clinical Microbiology and Infection

G.C. Schito Clinical Microbiology and Infection

Great oaks from little acorns grow—21 years of CMI

Impact of antibiotic restrictions: the patient's perspective

CMI readers' survey Clinical Microbiology and Infection

The future of diagnostic bacteriology

Presentation transcript:

Control of multidrug-resistant Gram-negative bacteria in low- and middle-income countries—high impact interventions without much resources N. Singh, V. Manchanda Clinical Microbiology and Infection Volume 23, Issue 4, Pages 216-218 (April 2017) DOI: 10.1016/j.cmi.2017.02.034 Copyright © 2017 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions

Fig. 1 Conceptual framework for global antimicrobial resistance surveillance. Adapted from Singh/Stelling https://www.folkhalsomyndigheten.se/amr-stockholm-2014/ Clinical Microbiology and Infection 2017 23, 216-218DOI: (10.1016/j.cmi.2017.02.034) Copyright © 2017 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions